This position supportsthe Medical Affairs organization of Sanofi-Genzyme, with a focus on the RareBleeding Disorder Unit and the Medical Affairs Global Support Functions.
The position reports to the Head ofFinance for Sanofi Genzyme Medical Affairs and is based in Cambridge, MA.
The position is responsible forproviding financial support to the Senior Management teams of the Rare Bleedingand Global Support Functions organization while successfully monitoring keyfinancial processes for the supported areas.
Primary responsibilities include:
Budgeting and forecasting
Month end close accounting and reporting requirements
Business Partnership, Operating expenses controlling and
The ideal candidate is expected toprovide valuable insight and recommendation to his/her business partners toreach financial targets, while being an active member of the Sanofi-GenzymeMedical Affairs finance team.
Budgeting and Forecasting
Responsible for working inclose relationship with the Rare Bleeding Disorder and Global Support functions
Management teams in the development of expense budgets for the annual operatingbudget, forecasts and long range plan.
Global responsibility, requiring close collaboration and alignmentwith the Global and regional teams located in the US, Europe and Japac
Submission including Headcount and related expenses, projects andclinical studies costs
Variance analysis and commentary
Validating data, submission in Financesystems, generating reports and creating PowerPoint management presentations
Provide Business Partners with clearexplanation on drivers of their revised plan enabling them to be prepared forpresentations to GLT (Global Leadership Team)
Month End Close Accounting and
Responsible for performing keymonth-end close accounting activities and reporting requirements in relationwith the Medical Affairs finance team (running some of the closing activitiesacross all perimeters) and in compliance with all applicable accountingstandards, statutory requirements and corporate reporting requirements andtimelines.
Booking and Validation of journal entries, preparing accountreconciliations
Month-end commentary and reporting package for the Sanofi USfinance team
Monthly analysis and comment for Business Partners.
Business Partnership, OperatingExpense Controlling and Compliance
Becoming the trusted financeinterlocutor of the heads of the Medical Rare Bleeding Disorder and GlobalSupport functions and their Senior Management teams.
Own communication around month end close calendar, deadlines anddeliverables
Conduct financial reviews of budgets and spending to identify,assess and investigate budget variances, presenting and commenting on financialperformance, staffing and other key financial metrics on a regular basis.
Responsible for managing the day to day Medical Operations expenses,including review and approval of Purchase Orders of project related initiativesand outsourced services according to Sanofi Governance and Complianceprocesses.
Monitoring of spending for clinical studies in liaison withrelevant support functions
Financial support for ad-hocProject
Provide technical and analyticalsupport for numerous projects and analyses to support achievement of SanofiGenzyme Medical Affairs financial goals and business objectives, including theroll-out of a new SAP platform in 2019 as well as contribution to differentwork streams aiming at OPEX optimization and reporting solutions.
5+ years in business finance experience, with emphasis onfinancial analysis, budgeting, forecasting and month end close
Industry related experience a plus and/or willingness to learnabout the pharmaceutical industries and the therapeutic areas supported.
BS in Accounting/Finance required; CPA or MBA a plus
Strong working knowledge of Excel and Power-Point is critical
Strong accounting skills; Internal Controls
Knowledge of Hyperion, TM1 Cognos, SAP and Essbase preferred
Open minded and team player. Ability to work in a fast pacedenvironment and within a matrical organization
Excellent communication skills, ability to interact with SeniorLeaders
Bioverativ, a Sanofi company, is a global biotechnology company dedicated to transforming the lives of people with hemophilia and other rare blood disorders through world-class research, development and commercialization of innovative therapies. Launched in 2017 as an independent company spun out of Biogen's hemophilia business, we build upon a strong heritage of scientific innovation and are committed to actively working with the rare blood disorders community. The company's mission is to create progress for patients where they need it most and its hemophilia therapies when launched represented the first major advancements in hemophilia treatment in more than two decades. For more information, visit www.bioverativ.comOpens a New Window. or follow @bioverativ on Twitter.
We are an equal opportunity employer. We evaluate qualified applicants without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, veteran status, or any other protected characteristic. VEVRAA Federal Contractor
We Request Priority Protected Veteran and Disabled Referrals for all our locations.
Bioverativ is an E-Verify Employer in the United States.